Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Hepatocyte growth factor receptor antagonist PubMed
Primary Target
MET proto-oncogene, receptor tyrosine kinase

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 3 D009369 ClinicalTrials
Neoplasms 3 D009369 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Stomach Neoplasms 3 D013274 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Glioblastoma 2 D005909 ClinicalTrials
Lung Neoplasms 1 D008175 ClinicalTrials
Carcinoma, Hepatocellular 1 D006528 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1133766-06-9
ChEMBL CHEMBL1743051
FDA SRS MS1J9720WC
Guide to Pharmacology 8966